News
-
-
-
PRESS RELEASE
Avant Brands Strengthens Global Position with Strategic International Supply Agreements and 30+ New Product Rollout Across Canadian Provinces
Avant Brands Inc. announces strategic international supply agreements, focused product expansion in Canada, product innovation, Avant Medical relaunch, and director resignation. The company is positioned for sustained growth in the global cannabis market -
-
PRESS RELEASE
Vox Royalty Notes Development Decision at The Horseshoe Lights Project and Provides Western Australia Gold Market Update
Vox Royalty Corp. provides update on Horseshoe Lights copper-gold project in Western Australia & recent gold industry developments. Gold stockpiles fast-tracked for production -
PRESS RELEASE
Nextech's Map Dynamics Unveils Aggressive Growth Roadmap With Major Platform Upgrade Featuring AWS Integration, 95% Margins, Key Sales Hires
Nextech3D.ai announces major upgrade to Map Dynamics event platform, with AWS migration, new features, strategic sales hires, targeting music festivals, food expos and public shows, and AI matchmaking -
-
PRESS RELEASE
Mako Mining Announces Full Capital Recovery of Moss Mine Acquisition Cost; Restart of Gold Mining Activities Planned for Early July; Company Cash Balance Increases to US$27.4 million
Mako Mining Corp. announces full recovery of US$6.4 million acquisition cost for Moss Mine through cash flow. Strong operations at San Albino mine. New mine contractor engaged for Moss Mine. Cash to fund exploration and construction of Eagle Mountain Project -
PRESS RELEASE
CLINUVEL Update: CEO Comeback & US Expansion Drive: Vitiligo approval and M&A as growth catalysts in North America
CLINUVEL Pharmaceuticals Ltd. sets key strategic signals with CEO Dr. Philippe Wolgen's return and expansion into the North American market, targeting vitiligo approval and M&A for growth catalysts. Analysts confirm strong position and target price -
PRESS RELEASE
Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): Buy
Research update by Parmantier & Cie. GmbH on CLINUVEL Pharmaceuticals, highlighting CEO's return and business model enhancement with SCENESSE® for vitiligo in North America. Strategic growth opportunities discussed
